Ukraine’s health system presses on despite attacks, rising needs and looming winter - UN News

Lebanon’s president reaffirms the commitment to bring all arms under state control. Lebanon’s President Joseph Aoun has discussed the confiscation of explosives intended for use against Israel during a telephone call with United States Secretary of State Marco Rubio, the Lebanese Presidential Palace has announced. Aoun received the call on Thursday, assuring Rubio that Lebanese security forces are fully carrying out their duties in confiscating illicit arms across the country. Recommended Stories list of 3 itemslist 1 of 3How Israel’s ‘Yellow Line’ is reshaping southern Lebanonlist 2 of 3Israeli quadcopter drone drops bomb in Lebanonlist 3 of 3Suspected Israeli online operations cause alarm in Iran and Lebanonend of listLast week, an explosive-laden truck carrying 780kg (1,720lb) of explosives was intercepted on a highway between Beirut and the eastern Bekaa Valley. On Thursday, Hezbollah lawmaker Hassan Fadlallah acknowledged the group’s connection to the shipment, stating that the materials were intended for operations against Israel.

After $563 million in September storm losses, insurers want spending on infrastructure and prevention The Insurance Bureau of Canada (IBC) is calling on governments to spend more on flood prevention and to give Canadians access to flood risk information. It points to the September storms in southern Ontario as the latest warning of rising weather losses.

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.